A new study has confirmed the use of antibiotics for prolonged wet cough in children is the most effective treatment to prevent the illness from getting worse.
All news from Thoracic Medicine
It's the world's number one killer among infectious diseases, but tuberculosis has been eclipsed by HIV/AIDS as a focus of global attention and donor funding.
Researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition. The study was published in the journal Nature Communications.
The results of a large, international systematic review published in the journal PLOS Medicine show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis (MDR-TB). The study was used to inform the World Health Organization guidelines on treatment of MDR-TB in children.
Global tuberculosis control and elimination will require detailed real-time information on the location of individuals with the disease, the presence of drug resistance, and the patterns of transmission. The surveys currently used are only conducted periodically and are not sufficient to effectively control tuberculosis, which causes more than 4,500 deaths daily.
A group of researchers used a systematic approach to get an entirely new look at the way tuberculosis infects people. Their study uncovered interactions between tuberculosis and human proteins that could provide new approaches to combat infection.
A new study suggests that long-term exposure to secondhand smoke during childhood increases the risk of chronic obstructive pulmonary disease (COPD) death in adulthood. The study also suggests secondhand smoke exposure as an adult increases the risk of death not only from COPD but also several other conditions.
The Committee for Medicinal Products for Human Use of the European Medicines Agency voted on July 26 to recommend the combination treatment tezacaftor 100 mg and ivacaftor 150 mg (Symkevi, Vertex Pharmaceuticals [Europe]) for patients aged 12 years and older who have an underlying cause of cystic fibrosis (CF).
Privately held Celtaxsys Inc said, a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function.
Just 60% of low-income urban preschoolers with asthma have the medications they need available at home, new findings from the U.S. show.
Drugs like crizotinib are used to treat patients with ROS1-positive lung cancer. But which patients are ROS1-positive? A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology shows that common laboratory tests used to determine ROS1 status all have inherent limitations that can lead to false-negative results.
According to a new report released in Geneva, Child tuberculosis has grown into a ‘silent epidemic’ as 90% of children who die from TB every year went untreated worldwide.